NDC Package 83021-774-15 Anubismed

Aloe Barbadensis Leaf Extract,Propylene Glycol,Cetearyl Ethylhexanoate Cream Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
83021-774-15
Package Description:
15 mL in 1 TUBE
Product Code:
Proprietary Name:
Anubismed
Non-Proprietary Name:
Aloe Barbadensis Leaf Extract, Propylene Glycol, Cetearyl Ethylhexanoate
Substance Name:
1,2-hexanediol; Allantoin; Aloe Vera Leaf; Argan Oil; Butylated Hydroxytoluene; Butyrospermum Parkii (shea) Butter Unsaponifiables; C12-20 Acid Peg-8 Ester; Caprylyl Glycol; Carbomer Homopolymer, Unspecified Type; Decyl Oleate; Fragrance 13576; Glycerin; Grape Seed Oil; Hexamethylene Diisocyanate/trimethylol Hexyllactone Crosspolymer; Imidurea; Medium-chain Triglycerides; Propylene Glycol; Silicon Dioxide; Tocopherol; Trolamine; Tropolone; Water
11-Digit NDC Billing Format:
83021077415
Product Type:
Human Otc Drug
Labeler Name:
Anubis Cosmetics Sl
Dosage Form:
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Sample Package:
    No
    FDA Application Number:
    M016
    Marketing Category:
    OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
    Start Marketing Date:
    10-14-2022
    End Marketing Date:
    02-03-2026
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 83021-774-15?

    The NDC Packaged Code 83021-774-15 is assigned to a package of 15 ml in 1 tube of Anubismed, a human over the counter drug labeled by Anubis Cosmetics Sl. The product's dosage form is cream and is administered via topical form.

    Is NDC 83021-774 included in the NDC Directory?

    Yes, Anubismed with product code 83021-774 is active and included in the NDC Directory. The product was first marketed by Anubis Cosmetics Sl on October 14, 2022.

    What is the 11-digit format for NDC 83021-774-15?

    The 11-digit format is 83021077415. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-283021-774-155-4-283021-0774-15